Holen Sie sich die Stockscreener-App
5.09
2.49%
-0.13
Handel nachbörslich:
5.09
Schlusskurs vom Vortag:
$5.22
Offen:
$5.11
24-Stunden-Volumen:
1.65M
Relative Volume:
0.99
Marktkapitalisierung:
$275.83M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-54.19M
KGV:
-1.9729
EPS:
-2.58
Netto-Cashflow:
$-37.34M
1W Leistung:
-3.42%
1M Leistung:
-0.78%
6M Leistung:
-12.84%
1J Leistung:
-14.60%
1-Tages-Spanne:
$5.0217
$5.165
1-Wochen-Bereich:
$5.0217
$5.40
52-Wochen-Spanne:
$3.9328
$7.5401
Abeona Therapeutics Inc Stock (ABEO) Company Profile
Firmenname
Abeona Therapeutics Inc
Sektor
Branche
Telefon
646-813-4701
Adresse
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY
Vergleichen Sie ABEO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABEO
Abeona Therapeutics Inc
|
5.09 | 282.88M | 0 | -54.19M | -37.34M | -2.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-03-05 | Eingeleitet | Oppenheimer | Outperform |
| 2024-07-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-05-30 | Eingeleitet | Stifel | Buy |
| 2020-11-11 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2020-09-18 | Eingeleitet | B. Riley FBR | Buy |
| 2020-02-10 | Eingeleitet | SVB Leerink | Outperform |
| 2019-12-10 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2019-08-15 | Herabstufung | Maxim Group | Buy → Hold |
| 2019-08-12 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2019-07-26 | Herabstufung | Mizuho | Buy → Neutral |
| 2019-06-27 | Eingeleitet | Mizuho | Buy |
| 2018-10-12 | Eingeleitet | Mizuho | Buy |
| 2018-06-05 | Eingeleitet | Seaport Global Securities | Buy |
| 2017-11-08 | Eingeleitet | SunTrust | Buy |
| 2017-10-16 | Bestätigt | H.C. Wainwright | Buy |
| 2017-10-11 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-10-10 | Eingeleitet | Citigroup | Buy |
| 2017-10-05 | Bestätigt | Maxim Group | Buy |
| 2017-09-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2017-07-18 | Bestätigt | Maxim Group | Buy |
| 2017-06-22 | Fortgesetzt | Jefferies | Buy |
| 2017-01-06 | Eingeleitet | Jefferies | Buy |
| 2016-09-29 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Abeona Therapeutics Inc Aktie (ABEO) Neueste Nachrichten
Is Abeona Therapeutics Inc. (PCJ) stock inflation resilient2025 Bull vs Bear & Daily Technical Stock Forecast Reports - ulpravda.ru
How Abeona Therapeutics Inc. stock compares to industry benchmarksWeekly Trend Recap & Weekly High Potential Stock Alerts - ulpravda.ru
Why Abeona Therapeutics Inc. stock remains a top recommendation - ulpravda.ru
Will Abeona Therapeutics Inc. (PCJ) stock draw ESG focused funds2026 world cup usa national team round of 32 defensive leaders counter attacking knockout prediction guide - ulpravda.ru
Trading Systems Reacting to (ABEO) Volatility - Stock Traders Daily
3 Insider-Owned Growth Stocks For Your Watchlist - simplywall.st
Abeona Therapeutics announces employee inducement grants - MSN
Abeona Therapeutics (ABEO) Issues Equity Awards to New Staff - GuruFocus
Abeona Therapeutics® announces new employee inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView — Track All Markets
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Abeona Therapeutics Inc. (NASDAQ:ABEO) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Insider Sell: Vishwas Seshadri Sells 25,000 Shares of Abeona The - GuruFocus
Abeona Therapeutics (NASDAQ:ABEO) CEO Vishwas Seshadri Sells 25,000 Shares - MarketBeat
Avoiding Lag: Real-Time Signals in (ABEO) Movement - Stock Traders Daily
Abeona Therapeutics Inc. (ABEO) Stock Analysis: Exploring a Potential 281% Upside in Gene Therapy - DirectorsTalk Interviews
Is Abeona Therapeutics Inc. stock dividend yield sustainableEarnings Growth Summary & Risk Adjusted Buy/Sell Alerts - Улправда
Short Covering: Why institutional investors increase stakes in Abeona Therapeutics Inc. (PCJ) stockM&A Rumor & Weekly High Momentum Picks - Улправда
How Abeona Therapeutics Inc. stock performs in stagflation2025 Geopolitical Influence & Weekly Watchlist for Hot Stocks - Улправда
How Abeona Therapeutics Inc. stock performs in high volatility markets2025 Valuation Update & Precise Trade Entry Recommendations - Улправда
Can Abeona Therapeutics Inc. stock reach $100 price targetPortfolio Growth Summary & Low Risk High Win Rate Picks - ulpravda.ru
How Abeona Therapeutics Inc. stock reacts to global recession fearsTrade Entry Report & Real-Time Price Movement Reports - ulpravda.ru
Abeona Therapeutics appoints Mohamad Tabrizi as chief business officer By Investing.com - Investing.com Nigeria
Abeona Therapeutics appoints Mohamad Tabrizi as chief business officer - Investing.com
Abeona Therapeutics names Mohamad Tabrizi as chief business officer - marketscreener.com
Abeona Therapeutics Appoints Mohamad Tabrizi as Senior Vice President, Chief Business Officer - Quiver Quantitative
Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer - marketscreener.com
(ABEO) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
Quarterly Earnings: Will Abeona Therapeutics Inc stock benefit from M A activityJuly 2025 Sector Moves & Safe Capital Growth Tips - moha.gov.vn
AWM Investment Company Inc. Acquires New Shares in Abeona Therapeutics Inc. $ABEO - MarketBeat
Boone Capital Management LLC Makes New Investment in Abeona Therapeutics Inc. $ABEO - MarketBeat
Abeona Therapeutics (NASDAQ:ABEO) Share Price Passes Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Abeona Therapeutics (ABEO) Expands Zevaskyn Treatment Access in Texas - GuruFocus
Abeona Therapeutics Activates New Qualified Treatment Center for ZEVASKYN in Texas - Quiver Quantitative
Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in Texas - GlobeNewswire
University of Texas Medical Branch activated as treatment center for RDEB therapy - Investing.com
Is Abeona Therapeutics Inc a good long term investment - earlytimes.in
Abeona Therapeutics (ABEO) Begins First Commercial Use of ZEVASK - GuruFocus
Abeona Therapeutics® Announces First Patient Treatment with ZEVASKYN® Gene Therapy - The Manila Times
Abeona Therapeutics Announces First Commercial Patient Treatment with FDA-Approved ZEVASKYN for Recessive Dystrophic Epidermolysis Bullosa - Quiver Quantitative
Abeona Therapeutics (Nasdaq: ABEO) begins commercial use of FDA-approved ZEVASKYN for RDEB - Stock Titan
Is Abeona Therapeutics Stock Built to Withstand a Pullback? - Trefis
Abeona Therapeutics Inc. (NASDAQ:ABEO) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
What makes Abeona Therapeutics Inc. stock attractive to growth funds2025 Performance Recap & Reliable Intraday Trade Plans - Newser
Will Abeona Therapeutics Inc. stock see PE expansionSell Signal & Free Weekly Chart Analysis and Trade Guides - Newser
Can Abeona Therapeutics Inc. (PCJ) stock survive global slowdownJuly 2025 Institutional & Verified Trade Idea Suggestions - Newser
How forex fluctuations impact Abeona Therapeutics Inc. (PCJ) stockMarket Growth Summary & Expert Curated Trade Ideas - Newser
How strong is Abeona Therapeutics Inc. stock balance sheetVolume Spike & Community Trade Idea Sharing - Newser
Abeona Therapeutics (ABEO) Stock Analysis Report | Financials & Insights - Benzinga
Why retail traders accumulate Abeona Therapeutics Inc. (PCJ) stockMarket Sentiment Summary & AI Optimized Trading Strategy Guides - Newser
Can Abeona Therapeutics Inc. (PCJ) stock sustain revenue momentumJuly 2025 WrapUp & Real-Time Volume Trigger Notifications - Newser
Finanzdaten der Abeona Therapeutics Inc-Aktie (ABEO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
4.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):